88.00
+2.1(+2.44%)
Currency In CHF
Address
Untere Bruehlstrasse 4
Zofingen, 4800
Switzerland
Phone
41 62 746 1111
Website
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
3886
First IPO Date
April 14, 1995
| Name | Title | Pay | Year Born |
| Mr. Marcel Imwinkelried | Chief Executive Officer & Chief Operating Officer Drug Products ad interim | 1.29M | 1967 |
| Mr. Stefan Randl | Chief Scientific Officer | 0 | N/A |
| Dr. Reto Suter Ph.D. | Chief Financial Officer | 0 | 1971 |
| Beatrice Harder | Head Regulatory Affairs - Site Zofingen | 0 | N/A |
| Mr. Peter Stierli | Head of Corporate Communications | 0 | N/A |
| Ms. Olesia Silanteva | Chief Human Resources Officer | 0 | 1982 |
| Ms. Marianne Spane | Chief Business Officer of Drug Substances & Drug Products | 0 | 1962 |
| Mr. Enno Schweinberger Ph.D. | Head Global Quality Management DS - Zofingen | 0 | N/A |
| John Jones | Head of Operations - Malta | 0 | N/A |
| Dr. Luca Dalla Torre | Chief Legal & Sustainability Officer | 0 | N/A |
Siegfried Holding AG engages in the life sciences business worldwide. The company develops and produces active pharmaceutical ingredients (APIs) and intermediates, as well as finished dosage forms, including solid oral dosage forms, and sterile and aseptic filling injectables, ophthalmics, and inhalative products. It offers contract development and manufacturing services, including pharmaceutical and analytical development, process and analytical transfer, commercial manufacturing and packaging, and scale up and clinical trial material production. In addition, the company provides APIs and controlled substances focusing on anesthetics, pain treatment applications, and central nervous and respiratory diseases. Further, it licenses oral solid and sterile products; assembles registration dossiers; and offers a common technical document for various products. The company was founded in 1873 and is headquartered in Zofingen, Switzerland.